|Bid||0.00 x N/A|
|Ask||0.00 x N/A|
|Day's range||9.10 - 9.10|
|52-week range||9.10 - 9.10|
|Beta (5Y monthly)||1.46|
|PE ratio (TTM)||N/A|
|Earnings date||26 May 2021 - 31 May 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
The Sonic Fund II, L.P. ("Sonic"), which beneficially owns approximately 6.8% of the outstanding common stock of Adverum Biotechnologies, Inc. (NASDAQ: ADVM) (the "Company" or "Adverum"), announced today that it has filed a definitive proxy statement and GREEN proxy card with the SEC in conjunction with the 2021 Annual Meeting of Stockholders (the "2021 Annual Meeting") that the Company is rushing to hold on May 12, 2021. Sonic has nominated three independent, highly qualified director candidates – Jean Bennett, Jodi Cook and Herbert Hughes (the "Nominees") – for election to the Adverum Board of Directors (the "Board") to serve until the 2024 Annual Meeting.
Investors need to pay close attention to Adverum Biotechnologies (ADVM) stock based on the movements in the options market lately.
ADVM earnings call for the period ending December 31, 2020.